Search

everythinglearnresearchcommunity

for

Search:↓

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

Higher doses of spironolactone may improve acne in PCOS patients, but side effects are a concern.

Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

17α-estradiol lotion can reduce hair loss but doesn't promote new hair growth.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Low-dose oral minoxidil improved hair growth when topical treatments failed.

A woman experienced hair loss after taking strontium ranelate for osteoporosis.

The document describes a treatment for excessive hair growth in a teenage girl using medication and birth control, but does not report the results.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Spironolactone is generally safe and effective for treating hair loss in women, but may be less effective in severe cases.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

Spironolactone and clascoterone are promising acne treatments with fewer side effects.

The inhibitor affects androgen metabolism but not ovarian function.

Stigmasterol may help treat hair loss, but more research is needed.

A 1-day or 3-day itraconazole treatment is effective for acute vulvovaginal candidosis, but recurrent cases may need longer treatment.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.